Identification Generic Name ({[(3E)-2'-Oxo-2',7'-dihydro-2,3'-biindol-3(7H)-ylidene]amino}oxy)acetic acid DrugBank Accession Number DB07949 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for ({[(3E)-2'-Oxo-2',7'-dihydro-2,3'-biindol-3(7H)-ylidene]amino}oxy)acetic acid (DB07949) ×  Close Weight Average: 335.3135  Monoisotopic: 335.090605919  Chemical Formula C 18 H 13 N 3 O 4 Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Glycogen phosphorylase, muscle form Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as indoles and derivatives. These are organic compounds containing an indole, which is a bicyclic ring system made up of a six-membered benzene ring fused to a five-membered nitrogen-containing pyrrole ring. Kingdom Organic compounds Super Class Organoheterocyclic compounds Class Indoles and derivatives Sub Class Not Available Direct Parent Indoles and derivatives Alternative Parents Pyrrolines  /  Oxime ethers  /  N-acylimines  /  Ketimines  /  Propargyl-type 1,3-dipolar organic compounds  /  Monocarboxylic acids and derivatives  /  Carboxylic acids  /  Azacyclic compounds  /  Organopnictogen compounds  /  Organic oxides  /  Hydrocarbon derivatives  /  Carbonyl compounds 
 
 
  show 2 more Substituents Aliphatic heteropolycyclic compound  /  Azacycle  /  Carbonyl group  /  Carboxylic acid  /  Carboxylic acid derivative  /  Hydrocarbon derivative  /  Imine  /  Indole or derivatives  /  Ketimine  /  Monocarboxylic acid or derivatives  /  N-acylimine  /  Organic 1,3-dipolar compound  /  Organic nitrogen compound  /  Organic oxide  /  Organic oxygen compound  /  Organonitrogen compound  /  Organooxygen compound  /  Organopnictogen compound  /  Oxime ether  /  Propargyl-type 1,3-dipolar organic compound  /  Pyrroline 
 
 
  show 11 more Molecular Framework Aliphatic heteropolycyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key BFQRPTKOSYMPOL-LALPNIDTSA-N InChI InChI=1S/C18H13N3O4/c22-14(23)9-25-21-16-11-6-2-4-8-13(11)19-17(16)15-10-5-1-3-7-12(10)20-18(15)24/h1-6H,7-9H2,(H,22,23)/b17-15-,21-16+ IUPAC Name 2-({[(Z,3E)-2'-oxo-3,7-dihydro-2'H,7'H-[2,3'-biindolyliden]-3-ylidene]amino}oxy)acetic acid SMILES OC(=O)CO\N=C1/C2=CC=CCC2=N/C/1=C1\C(=O)N=C2CC=CC=C12 References General References Not Available External Links PubChem Compound 11840955 PubChem Substance 99444420 ChemSpider 10015460 ZINC ZINC000095920659 PDBe Ligand IAA PDB Entries 1z62 Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.0442 mg/mL ALOGPS logP 2.6 ALOGPS logP 0.96 Chemaxon logS -3.9 ALOGPS pKa (Strongest Acidic) 3.47 Chemaxon pKa (Strongest Basic) 1.97 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 7 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 100.68 Å 2 Chemaxon Rotatable Bond Count 3 Chemaxon Refractivity 94.04 m 3 ·mol -1 Chemaxon Polarizability 34.43 Å 3 Chemaxon Number of Rings 4 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.9818 Blood Brain Barrier + 0.6119 Caco-2 permeable - 0.6094 P-glycoprotein substrate Non-substrate 0.5435 P-glycoprotein inhibitor I Non-inhibitor 0.63 P-glycoprotein inhibitor II Non-inhibitor 0.6773 Renal organic cation transporter Non-inhibitor 0.802 CYP450 2C9 substrate Non-substrate 0.8209 CYP450 2D6 substrate Non-substrate 0.829 CYP450 3A4 substrate Substrate 0.6465 CYP450 1A2 substrate Non-inhibitor 0.507 CYP450 2C9 inhibitor Non-inhibitor 0.581 CYP450 2D6 inhibitor Non-inhibitor 0.8847 CYP450 2C19 inhibitor Non-inhibitor 0.5469 CYP450 3A4 inhibitor Non-inhibitor 0.764 CYP450 inhibitory promiscuity High CYP Inhibitory Promiscuity 0.5085 Ames test Non AMES toxic 0.5343 Carcinogenicity Non-carcinogens 0.8338 Biodegradation Not ready biodegradable 0.9825 Rat acute toxicity 2.4272 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.995 hERG inhibition (predictor II) Non-inhibitor 0.9032    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  Glycogen phosphorylase, muscle form Kind Protein Organism Humans Pharmacological action Unknown General Function Pyridoxal phosphate binding Specific Function Phosphorylase is an important allosteric enzyme in carbohydrate metabolism. Enzymes from different sources differ in their regulatory mechanisms and in their natural substrates. However, all known ... Gene Name PYGM Uniprot ID P11217 Uniprot Name Glycogen phosphorylase, muscle form Molecular Weight 97091.265 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:27 / Updated at June 24, 2020 01:34 